{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:31:32Z","timestamp":1786717892552,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/1673-5374.193224","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T08:05:17Z","timestamp":1477641917000},"page":"1553","source":"Crossref","is-referenced-by-count":35,"title":["Impairment of the nerve growth factor pathway driving amyloid accumulation in cholinergic neurons: the incipit of the Alzheimer\u2032s disease story?"],"prefix":"10.4103","volume":"11","author":[{"given":"Viviana","family":"Triaca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Calissano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.193224-1","doi-asserted-by":"crossref","unstructured":"Baker-Nigh A, Vahedi S, Davis EG, Weintraub S, Bigio EH, Klein WL, Geula C (2015) Neuronal amyloid-\u03b2 accumulation within cholinergic basal forebrain in ageing and Alzheimer\u2032s disease. Brain 138:1722-1737.","DOI":"10.1093\/brain\/awv024"},{"key":"key-10.4103\/1673-5374.193224-2","unstructured":"Bayer TA, Wirths O (2010) Intracellular accumulation of amyloid-beta, a predictor for synaptic dysfunction and neuron loss in Alzheimer\u2032s disease. Front Aging Neurosci 2:8."},{"key":"key-10.4103\/1673-5374.193224-3","doi-asserted-by":"crossref","unstructured":"Calissano P, Amadoro G, Matrone C, Ciafre S, Marolda R, Corsetti V, Ciotti MT, Mercanti D, Di Luzio A, Severini C, Provenzano C, Canu N (2010) Does the term \u2032trophic\u2032 actually mean anti-amyloidogenic? The case of NGF. Cell Death Differ 17:1126-1133.","DOI":"10.1038\/cdd.2010.38"},{"key":"key-10.4103\/1673-5374.193224-4","doi-asserted-by":"crossref","unstructured":"Iulita MF, Cuello AC (2014) Nerve growth factor metabolic dysfunction in Alzheimer\u2032s disease and Down syndrome. Trends Pharmacol Sci 35:338-348.","DOI":"10.1016\/j.tips.2014.04.010"},{"key":"key-10.4103\/1673-5374.193224-5","doi-asserted-by":"crossref","unstructured":"Kim S, Sato Y, Mohan PS, Peterhoff C, Pensalfini A, Rigoglioso A, Jiang Y, Nixon RA (2016) Evidence that the rab5 effector APPL1 mediates APP-\u03b2 CTF-induced dysfunction of endosomes in Down syndrome and Alzheimer\u2032s disease. Mol Psychiatry 21:707-716.","DOI":"10.1038\/mp.2015.97"},{"key":"key-10.4103\/1673-5374.193224-6","doi-asserted-by":"crossref","unstructured":"LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer\u2032s disease. Nat Rev Neurosci 8:499-509.","DOI":"10.1038\/nrn2168"},{"key":"key-10.4103\/1673-5374.193224-7","doi-asserted-by":"crossref","unstructured":"Lee MS, Kao SC, Lemere CA, Xia W, Tseng HC, Zhou Y, Neve R, Ahlijanian MK, Tsai LH (2003) APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 163:83-95.","DOI":"10.1083\/jcb.200301115"},{"key":"key-10.4103\/1673-5374.193224-8","doi-asserted-by":"crossref","unstructured":"Mesulam M (2004) The cholinergic lesion of Alzheimer\u2032s disease: pivotal factor or side show? Learn Mem 11:43-49.","DOI":"10.1101\/lm.69204"},{"key":"key-10.4103\/1673-5374.193224-9","doi-asserted-by":"crossref","unstructured":"Mufson EJ, He B, Nadeem M, Perez SE, Counts SE, Leurgans S, Fritz J, Lah J, Ginsberg SD, Wuu J, Scheff SW (2012) Hippocampal proNGF signaling pathways and \u03b2-amyloid levels in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol 71:1018-1029. .","DOI":"10.1097\/NEN.0b013e318272caab"},{"key":"key-10.4103\/1673-5374.193224-10","doi-asserted-by":"crossref","unstructured":"Ruberti F, Capsoni S, Comparini A, Di Daniel E, Franzot J, Gonfloni S, Rossi G, Berardi N, Cattaneo A (2000) Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J Neurosci 20:2589-2601.","DOI":"10.1523\/JNEUROSCI.20-07-02589.2000"},{"key":"key-10.4103\/1673-5374.193224-11","doi-asserted-by":"crossref","unstructured":"Shinohara M, Fujioka S, Murray ME, Wojtas A, Baker M, Rovelet-Lecrux A, Rademakers R, Das P, Parisi JE, Graff-Radford NR, Petersen RC, Dickson DW, Bu G (2014) Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer\u2032s disease. Brain 137:1533-1549.","DOI":"10.1093\/brain\/awu046"},{"key":"key-10.4103\/1673-5374.193224-12","doi-asserted-by":"crossref","unstructured":"Tuszynski MH, Yang JH, Barba D, U HS, Bakay RA, Pay MM, Masliah E, Conner JM, Kobalka P, Roy S, Nagahara AH (2015) Nerve growth factor gene therapy: activation of neuronal responses in Alzheimer disease. JAMA Neurol 72:1139-1147.","DOI":"10.1001\/jamaneurol.2015.1807"},{"key":"key-10.4103\/1673-5374.193224-13","doi-asserted-by":"crossref","unstructured":"Xu W, Weissmiller AM, White JA 2nd, Fang F, Wang X, Wu Y, Pearn ML, Zhao X, Sawa M, Chen S, Gunawardena S, Ding J, Mobley WC, Wu C (2016) Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration. J Clin Invest 126:1815-1833.","DOI":"10.1172\/JCI82409"},{"key":"key-10.4103\/1673-5374.193224-14","doi-asserted-by":"crossref","unstructured":"Yang C, Liu Y, Ni X, Li N, Zhang B, Fang X (2014) Enhancement of the nonamyloidogenic pathway by exogenous NGF in an Alzheimer transgenic mouse model. Neuropeptides 48:233-238.","DOI":"10.1016\/j.npep.2014.04.005"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:29:01Z","timestamp":1786714141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.193224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"alternative-id":["193224"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.193224","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}